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Abstract 
 
Background:. A3243G mutation in tRNA Leu (UUR) 
leads to a specific clinical syndrome characterized by 
diabetes and sensorineural hearing defect, hence called as 
“Maternally Inherited Diabetes and Deafness (MIDD)”.. 
Methods: The study was retrospective, analytical case 
control study. Non - probability convenient sampling 
technique was used. Subjects were divided into two 
groups. Thirty-nine patients with phenotype of 
mitochondrial diabetes and a strong maternal history of 
diabetes (group 1) and 40 non – diabetic individuals 
(controls) with no maternal history of diabetes (group 2). 
MtDNA, isolated from peripheral blood leukocytes, was 
analyzed to detect A3243G tRNALeu(UUR) gene mutation 
.Results: In spite of the presence of characteristic features 
of maternally inherited diabetes and deafness, A3243G 
tRNALeu(UUR) gene mutation was absent in patients and 
controls. Mean age of onset of diabetes was +34.06 years 
and of deafness was +47.56 years. Mean plasma glucose, 
HbA1c, cholesterol and triglyceride level in patients was 
significantly higher (p< 0.001) whereas body mass index 
(BMI) of diabetics was significantly low (p< 0.001) as 
compared with controls.  
Conclusion: Although A3243G tRNALeu(UUR) gene 
mutation was not likely to be a frequent cause of 
mitochondrial diabetes in selected group of patients, other 
mitochondrial diabetogenic mutations as well as 
mechanisms involved in pathogenesis of mitochondrial 
diabetes must be considered.  
Key Words: Mitochondrial DNA (mtDNA), maternally 
inherited diabetes and deafness (MIDD), body mass index 
(BMI), transfer RNA (tRNA). 
 
Introduction 
 
Diabetes Mellitus (DM) is a frequently 
occurring, multifactorial disorder with increasing 
pandemic frequency 1 . Surprisingly, for the last few 
years, a new trend in development of type 2 diabetes 
mellitus (T2DM) has been noticed  i.e. onset of 
diabetes at the age of 30 – 40 years, instead of late 40s 
and secondly, diabetics with early onset of T2DM have 
low body mass index 2. The genetic cause of early 
onset of diabetes has been a hot point of research for 
several decades and is yet to be explored further but 
the progression in this domain has been facing many 
difficulties making the situation  complicated.In 
addition to nuclear genome, mitochondrial genome 
has been studied thoroughly for the last few decades 
to find out its association with the pathogenesis of 
type 2 diabetes mellitus  3 .  
Ubiquitous intracellular organelles, 
mitochondria, are involved in many metabolic 
pathways including energy generation by oxidative 
phosphorylation (OXPHOS) to keep the cells alive and 
functional. OXPHOS generates energy rich phosphate 
compounds i.e. Adenosine Triphosphate (ATP). ATP 
provides energy to all metabolic processes and 
physical activities going on. In addition, ATP also 
plays a pivotal role in the synthesis and release of 
insulin by pancreatic beta cells, as β cells are sensitive 
to hyperglycemia. Raised blood glucose alters the 
intracellular ATP/ADP ratio and triggers the release 
of insulin. Hence, ATP generation in pancreatic β cells 
is essential for its normal functioning. Most of the 
components of mitochondrial respiratory chain 
complexes are encoded by nuclear genome. However, 
few proteins subunits of mitochondrial respiratory 
chain complexes, are encoded by mtDNA. In 1963, 
Nass and Nass  demonstrated presence of 
extrachromosomal DNA within mitochondria called 
“Mitochondrial DNA”, (mtDNA) 4 . 
 Mutations of mtDNA are involved in several 
disorders and diabetes mellitus is a common and the 
predominant hallmark associated with various 
mitochondrial diseases 4 – 6 . Approximately twenty 
mtDNA mutations have been detected to be associated 
with mitochondrial diabetes, A3243G tRNALeu(UUR) 
gene mutation being the most common diabetogenic 
heteroplasmic point mutation in mtDNA. This 
mutation may lead to loss of mt transcription, 
translation and ultimately disturbed function of 
respiratory chain.  It has been detected in 0.5–1.5 % of 
the diabetics with T2DM 7 .  
A3243G  tRNALeu(UUR) gene mutation 
affects transcription and translation of mtDNA and is 
a major cause of maternally inherited diabetes 
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accompanied with sensorineural hearing defect- a new 
subtype of diabetes called “Maternally Inherited 
Diabetes and Deafness (MIDD)”.  Accompanying 
deafness may be due to the fact that the cells in the 
cochlear portion of the ear are also susceptible to 
energy deficit. Hence, any disruption in ATP 
production in cochlear cells can affect the normal 
hearing power of the patients with mitochondrial 
diabetes. This leads to the development of “Sensory-
neural deafness” along with diabetes. Hence, due to 
the combination of these two features, this disease got 
its present name of MIDD 8 . 
Other features of maternally inherited 
mitochondrial diabetes are early onset of diabetes i.e. 
age ≤ 40 yrs, insulin dependence at later stage, low or 
normal body mass index (BMI) and sensorineural 
hearing defect. The clinical features of mitochondrial 
diabetes linked with A3243G mutation has been 
discussed thoroughly by Chen YL et al. (2004) 9 . 
Regarding the mtDNA gene mutations 
associated with mitochondrial diabetes in Pakistan, no 
data is available. Therefore, this study was conducted 
to ascertain the presence of the most common 
diabetogenic mutation i.e. A3243G mutation in 
tRNALeu(UUR)  gene in the selected group of patients 
who presented with typical characteristic features of 
maternally inherited diabetes and deafness.  
 
 Patients and Methods 
 
This study was analytical case control study. 
Patients were selected from Military hospital, 
Rawalpindi, Combined Military hospital, Multan and 
rural areas near Chakri Road, Rawalpindi. This study 
was conducted from January 2005 to December 2008. 
Inclusion criteria were bilateral sensorineural deafness, 
onset of diabetes before the age of 40 years and insulin 
dependence, either at the time of diagnosis or later on. 
Audiometric services of the mentioned hospitals 
confirmed sensorineural hearing loss. Sample size was 
79. Subjects were subdivided into two groups, non-
diabetic controls with no maternal history of diabetes 
(n= 40) and patients with MIDD phenotype (n= 39).  
Molecular study was done at Centre for 
Research in Experimental and Applied Medicine 
(CREAM), Army Medical College, Rawalpindi. After 
getting written consent from the subjects, samples 
were scanned for the detection of potential mutations 
within the region of mitochondrial DNA 
tRNALeu(UUR) gene (np 3035 – 3456, 422 bp 
fragment) which contains the whole sequence of 
tRNALeu(UUR) gene.  
The genomic DNA was extracted from 
peripheral – blood leukocytes by Kit method 
(GENTRA, USA) followed by whole genomic 
amplification of mtDNA by using standard kit method 
(Qiagen Repli – G mitochondrial DNA kit). The 
required mtDNA fragment was amplified by PCR with 
AmpliTaq DNA polymerase. Two sets of primers were 
used. Forward Primer was 5’– 
CGTTTGTTCAACGATTAAAG –3’ and Reverse 
Primer was 5’– AGCGAAGGGTTGTACTAGCC –3’10.  
The amplified mtDNA 422 – bp fragments 
were digested by restriction enzyme ApaI (Fermentas 
Life Sciences) to identify any A3243G mutation 
followed by electrophoresis. The amplified PCR 
product was to split into 210 bp and 212 bp fragments 
if it had A3243G mutation to constitute the recognition 
site for ApaI. The PCR products were sequenced 
directly (Beckman Coulter, USA). 
Plasma glucose was estimated by enzymatic 
colorimetric method using glucose oxidase enzyme to 
oxidize glucose. Glycosylated hemoglobin (HbA1c) 
was determined by micro column method (ion 
exchange chromatography) 11. Plasma cholesterol and 
triglyceride level was determined by Enzymatic 
colorimetric method 12.  
Audiography 13 determined type and extent of 
hearing loss. 
Body mass index (BMI) was calculated by 
dividing Weight (Kg) by Height (m2 ) 14. 
Statistical data was analyzed by computer 
software programme “Statistical Package for Social 
Sciences (SPSS)” for windows, version 15.00 using 
Independent – Sample T-test. The results are expressed 
as mean ± s.e.m.  p- value less than 0.05 was taken as 
statistically significant. 
 
Results 
 
A3243G tRNALeu(UUR) gene mutation was not 
detected in two study groups (figure 1). Direct 
sequencing also confirmed these negative results (fig 2 
& 3).  
Mean age at which the patients developed 
diabetes mellitus was + 34.06 years and developed 
deafness at + 47.56 years. BMI was significantly low 
(p< 0.001), mean plasma glucose level and 
glycosylated hemoglobin level was significantly 
higher (p < 0.001) in diabetics as compared 
with controls. Plasma cholesterol and triglyceride 
level of patients was significantly higher (p< 0.001) as 
compared with controls (Table 1). 
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Figure 1: Electropherogram of Ethidium bromide 
stained 4 % agarose gel for ApaI – digestion of 422 bp 
segment of mitochondrial DNA showing no cleavage 
and absence of A3243G mutation in: 
Lane 1, 2: Patients with MIDD Phenotype 
Lane 3, 4:  Non – diabetic, controls. 
 
 
 
 
 
 
 
 
 
 
 
Figure 2:  Sequence alignment showing no A3243G 
mutation in mtDNA of patient with MIDD 
phenotype. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3:  Sequence alignment showing no A3243G 
mutation in mtDNA of Control. 
 
Discussion 
 
In this paper, the results of the search of 
A3243G mutation in maternally inherited type 2 
Diabetes in Pakistani population are reported. Though 
mtDNA A3243G mutation in the tRNALeu(UUR) gene 
could not be detected in the selected group of study 
but it is really difficult to reach a conclusion at this 
moment because an interaction of wide range of 
variants in mitochondrial DNA, nuclear DNA as well 
as environmental factors is involved in the 
development of MIDD. 
 
Table-1 
Comparison of various parameters of Group 
1 with Control Group.  
 
Patients with 
MIDD 
(n = 39) 
Controls 
(n = 40) 
Age at onset of 
diabetes (years) 34.06 + 5.23 --- 
Age at start of 
deafness (years) 
47.56 + 6.4 ( 
mean± SD*) ----- 
Body Mass Index 
(BMI) 20.06 + 0.29** 
24.52 + 
0.53 
Plasma Cholesterol 
(mmol/L) 6.054 + 0.24** 
4.78 + 
0.15 
Plasma Triglyceride 
(mmol/L) 1.78 + 0.04** 
1.32 + 
0.04 
Plasma glucose 
(mmol/L) 13.36 + 0.94** 
5.13 + 
0.08 
Glycosylated 
hemoglobin (mmol/L) 9.45+ 0.42** 
5.55 + 
0.10 
Glycosuria(%) 80 % Absent 
* SD: standard deviation 
**p < 0.001 as compared with normal control subjects  
 
Moreover, coordinated action of two genetic 
sources leads to the biogenesis of functional 
mitochondria i.e. nuclear genome and mitochondrial 
genome. Therefore, any defect in one of these genetic 
sources may contribute in the pathogenesis of 
mitochondrial diabetes 15. In addition, the level of 
heteroplasmy varies among different tissues being the 
highest in postmitotic tissues like pancreas, brain and 
skeletal muscles, and the lowest in rapidly dividing 
cells, such as blood leukocytes 16. Mitochondrial DNA 
was isolated from peripheral blood leucocytes. Hence, 
we cannot overlook the probability to miss the 
diabetogenic mtDNA mutation. Moreover, in 2001, 
similar study carried on Polish Population 17 revealed 
that out of 129 patients with maternally inherited type 
2 diabetes, none of the patients was identified as a 
carrier of A3243G mutation. In addition, two studies 
on South Indian adult patients with maternally 
inherited type 2 diabetes also did not report A3243G 
mutation 18. Nevertheless, the rising prevalence of 
MIDD in Asian countries cannot be underestimated, as 
recently Sahu . et al (2007) found mitochondrial DNA 
A3243G mutation in ~1% Asian subjects 2. 
Patients in our study group presented with 
422 bp 
DNA  
S     
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deafness for loud sounds, a characteristic feature of 
sensorineural hearing defect 19. No doubt, that the 
expected genetic cause responsible for MIDD 
phenotype was not be found, but to our knowledge, 
no other possible mechanism explains the etiology of 
deafness associated with maternally inherited type 2 
diabetes.  
Like type 2 diabetes, impaired hearing is also a 
multifactorial disorder. Several environmental and 
genetic factors can contribute in its pathogenesis like 
aging and autoimmune diseases. At the same time, 
several mitochondrial DNA mutations are associated 
with hearing loss e.g.  A1555G, A7445G, 7472insC and 
T7511C mutations 21. It is difficult to pin point the 
exact cause of deafness at this moment and the role of 
other etiological factors along with mtDNA mutations 
(other than A3243G) must be considered.  
Another significant finding in our study was 
low body mass index (BMI) in patients with 
maternally inherited type 2 diabetes. Although we 
realize that, the power to detect differences in this 
study was too small, any proof to show a definite 
association between MIDD phenotype and low BMI 
was difficult to provide. However, some recent studies 
have also shown the involvement of some other 
mtDNA mutations in the pathogenesis of diabetes, 
deafness and low BMI e.g. T1095C mutation 22. 
Therefore, there might be another significant etiology 
involved in the association of type 2 diabetes with low 
body mass index and deafness.  
Diabetics with MIDD phenotype belonged to a 
younger age group. For the last few years, it is seen 
that mostly patients develop type 2 diabetes in 
younger age i.e. between 30 – 40 years of age and have 
low BMI. As few studies conducted in Asia 2, one 
report from UK 19 and one from US 20 have also 
confirmed that a new trend of early onset of diabetes 
and low BMI is emerging as a significant feature of 
diabetes. Our study nevertheless provides a support 
for the hypothesis that mtDNA mutation may be an 
important genetic factor contributing to low BMI in 
maternally inherited diabetes. 
Thirty-four out of 39 patients (87.18 %) 
showed the insulin dependence, though initially oral 
hypoglycemics controlled the blood glucose level. 
Possible explanation of insulin dependence could be 
progressively worsening hyperglycemia or gradual 
increase in insulin requirement. Pronounced age-
dependent deterioration of beta pancreatic cells can 
also lead to decreased insulin production and 
enhanced insulin requirement 21. At the same time, 
other factors like severity of insulinopenia, 
hyperglucagonemia, lack of dietary education, low 
socioeconomic status and failure to take recommended 
balanced diet due to poverty must be considered as 
well 23.  
Marked dyslipidemia was another 
characteristic feature seen in diabetics with maternally 
inherited type 2 diabetes. Several studies conducted in 
Pakistan have shown that dyslipidemia is a prominent 
finding in diabetics 24, 25. Abbasi et al (2007) 26 reported 
raised plasma levels of cholesterol (total) and low 
density lipoproteins (LDL) as the only major finding in 
the Pakistani diabetics, particularly type 2 diabetes 
mellitus (T2DM). An electrifying rise, in the incidence 
of diabetes with dyslipidemia, is expected in the near 
future. Dyslipidemia seen in our study also confirmed 
the findings of the previous studies in our region. 
Our study had certain limitations. 
Unfortunately, the heteroplasmy of the mutation is the 
lowest in the peripheral blood leukocytes, most readily 
available sample, and the highest in the affected 
tissues. Moreover, there is ~0.7% decline in the 
heteroplasmy levels in leukocytes per year. Therefore, 
the chance to detect this mutation was lower in 
leukocytes and it might have hampered the detection 
of this mutation. As entire mitochondrial genome is 
susceptible to pathogenic mutations, comprehensive 
detection of mtDNA mutation requires sequencing of 
the entire mtDNA molecule, which could not be done 
due to lack of funds.  
Mitochondrial DNA encoded protein 
modelling may also be done to detect any alteration in 
the primary structure of proteins and their possible 
involvement in maternally inherited type 2 diabetes. 
Further study of families with non-syndromic hearing 
loss can lead to the better understanding of association 
of hearing loss and maternally inherited diabetes 
mellitus.  
The sequencing of the entire mtDNA can rule 
out the presence of known and novel mutations as 
well.  
 
Conclusion 
 
The A3243G mutation in mitochondrial 
tRNALeu(UUR) gene cannot be libelled as a main 
contributing etiological factor of type 2 diabetes in the 
selected group of patients. The observed clinical 
hallmarks of diabetes might be the outcome of a 
combination of several other mechanisms or factors. 
The exact prevalence of this mutation in Pakistani 
population can be determined by screening of larger 
study group. 
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